Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0853
Host Cell : CHO-K1 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0853 |
| Description | This cell line is engineered to stably overexpress monkey NCR1 (also named as NKp46). |
| Target Gene | NCR1 |
| Host Cell | CHO-K1 |
| Host Cell Species | Cricetulus griseus (Chinese hamster) |
| Applications |
1. Studying the interactions between immune cells and cancer cells 2. Studying the mechanisms of resistance to immune checkpoint blockade 3. High-throughput screening 4. Drug target validation |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
A: The stable expression of NCR1 in the Monkey NCR1 Stable Cell Line - CHO-K1 is achieved by introducing the NCR1 gene into CHO-K1 cells using genetic engineering techniques.
A: The role of NCR1 in viral infection processes can be investigated by modulating its expression levels in the Monkey NCR1 Stable Cell Line - CHO-K1. For example, RNA interference or CRISPR/Cas9 technology can be used to knock down or knockout the NCR1 gene, and observe changes in viral infection efficiency. In addition, NCR1 can be expressed in various types of viral infection models to study its functions in antiviral immunity.
A: The Monkey NCR1 Stable Cell Line - CHO-K1 can be used for screening potential drugs targeting NCR1. For example, high-throughput screening methods can be employed to identify small molecule compounds that can inhibit NCR1 activity or expression. These compounds can then be further studied for their antiviral activities, providing a foundation for the development of novel antiviral drugs.
A: One unique feature of the Monkey NCR1 Stable Cell Line - CHO-K1 is its stable expression of the NCR1 gene, which allows for consistent and reproducible studies of NCR1-mediated immune responses. Additionally, this cell line may have specific post-translational modifications or glycosylation patterns associated with CHO-K1 cells, which could influence NCR1 function. Researchers should consider these characteristics when comparing results with other cell lines or primary cells expressing NCR1.
A: Yes, the Monkey NCR1 Stable Cell Line - CHO-K1 can be used to model diseases or conditions related to NCR1 function. For example, researchers can use this cell line to investigate immune responses against cancer cells, as NCR1 is involved in the recognition and killing of tumor cells by NK cells. It can also be employed to study viral infections, as NCR1 is implicated in antiviral responses. By manipulating NCR1 expression and signaling in this cell line, researchers can gain insights into disease mechanisms and potential therapeutic interventions.
A: The Monkey NCR1 Stable Cell Line - CHO-K1 has several applications in research and biotechnology. It can be used to study the mechanisms of NCR1-mediated immune responses, including NK cell activation and cytotoxicity. Additionally, this cell line can be employed in drug screening assays to identify potential immunomodulatory compounds that target NCR1 signaling pathways. Furthermore, it may be used to develop therapeutic antibodies or biologics that modulate NCR1 function for cancer immunotherapy or other immune-related disorders.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.